Abstract:Disturbed remodeling of the extracellular matrix (ECM) is frequently observed in several high-prevalence pathologies that include fibrotic diseases of organs such as the heart, lung, periodontium, liver, and the stiffening of the ECM surrounding invasive cancers. In many of these lesions, matrix remodeling mediated by fibroblasts is dysregulated, in part by alterations to the regulatory and effector systems that synthesize and degrade collagen, and by alterations to the functions of the integrin-based adhesions that normally mediate mechanical remodeling of collagen fibrils. Cell-matrix adhesions containing collagen-binding integrins are enriched with regulatory and effector systems that initiate localized remodeling of pericellular collagen fibrils to maintain ECM homeostasis. A large cadre of regulatory molecules is enriched in cell-matrix adhesions that affect ECM remodeling through synthesis, degradation, and contraction of collagen fibrils. One of these regulatory molecules is Transient Receptor Potential Vanilloid-type 4 (TRPV4), a mechanically sensitive, Ca2+-permeable plasma membrane channel that regulates collagen remodeling. The gating of Ca2+ across the plasma membrane by TRPV4 and the consequent generation of intracellular Ca2+ signals affect several processes that determine the structural and mechanical properties of collagen-rich ECM. These processes include the synthesis of new collagen fibrils, tractional remodeling by contractile forces, and collagenolysis. While the specific mechanisms by which TRPV4 contributes to matrix remodeling are not well-defined, it is known that TRPV4 is activated by mechanical forces transmitted through collagen adhesion receptors. Here, we consider how TRPV4 expression and function contribute to physiological and pathological collagen remodeling and are associated with collagen adhesions. Over the long-term, an improved understanding of how TRPV4 regulates collagen remodeling could pave the way for new approaches to manage fibrotic lesions.

Collagen VIII in Vascular Diseases

Type VIII collagen

Collagens and collagen-related diseases

Role of thrombospondin-1 and thrombospondin-2 in cardiovascular diseases (Review)

Collagen Type I as a Ligand for Receptor-Mediated Signaling

Molecular and structural mapping of collagen fibril interactions

Collagen formation, function and role in kidney disease

Role of Collagen in Vascular Calcification

Collagen Structure-Function Mapping Informs Applications for Regenerative Medicine

Focus on TRPV4 and Collagen

Regulation of Collagen I and Collagen III in Tissue Injury and Regeneration

Collagen Alteration in Vascular Remodeling by Hemodynamic Factors.

Advances in the study of cartilaginous type X collagen

Collagen fiber regulation in human pediatric aortic valve development and disease

The Molecular Interaction of Collagen with Cell Receptors for Biological Function

Collagen XI Alpha 1 Chain, a Novel Therapeutic Target for Cancer Treatment

The Multifaced Role of Collagen in Cancer Development and Progression

Engineering Collagen-Based Biomaterials for Cardiovascular Medicine

Collagens—structure, function, and biosynthesis

The coordinated activities of collagen VI and XII in maintenance of tissue structure, function and repair: evidence for a physical interaction

Collagen structure and functional implications